Integrative analysis identifies two molecular and clinical subsets in Luminal B breast cancer - ScienceDirect
:max_bytes(150000):strip_icc()/GettyImages-1164234982-17a305f7dbaf4f4fb29ca25003cde65b.jpg "Luminal A Breast Cancer: Causes, Diagnosis, and Treatment")
Luminal A Breast Cancer: Causes, Diagnosis, and Treatment
Breast Cancer Subtypes And Prognosis | BCTT
Luminal breast cancer | BCTT
Basal-like carcinoma - Wikipedia
Overall survival depends on tumor subtype and systemic treatment. a... | Download Scientific Diagram
Breast Cancer Types | Breast Cancer Trials
Biomarker dynamics and prognosis in breast cancer after neoadjuvant chemotherapy | Scientific Reports
Frontiers | High Parity Predicts Poor Outcomes in Patients With Luminal B-Like (HER2 Negative) Early Breast Cancer: A Prospective Finnish Single-Center Study
Breast Cancer Subtypes And Prognosis | BCTT
:max_bytes(150000):strip_icc()/GettyImages-1389278061-ca025a5867e04ce18d7fc1b2ecba8ce2.jpg "Luminal B Breast Cancer: Symptoms, Diagnosis, and More")
Luminal B Breast Cancer: Symptoms, Diagnosis, and More
Five-year survival in luminal breast cancer patients: relation with intratumoral activity of proteasomes - Sereda - Translational Breast Cancer Research
Breast cancer-specific survival by body mass index categories for... | Download Scientific Diagram
Luminal B Breast Cancer: Molecular Characterization, Clinical Management, and Future Perspectives | Journal of Clinical Oncology
The regrouping of Luminal B (HER2 negative), a better discriminator of outcome and recurrence score - Yang - 2023 - Cancer Medicine - Wiley Online Library
Frontiers | Prognostic Relevance of Progesterone Receptor Levels in Early Luminal-Like HER2 Negative Breast Cancer Subtypes: A Retrospective Analysis
Luminal B Breast Cancer: Symptoms, Diagnosis, and Treatment
Biomedicines | Free Full-Text | Association between Obesity, Race or Ethnicity, and Luminal Subtypes of Breast Cancer
Luminal B Breast Cancer: Symptoms, Diagnosis, and Treatment
Frontiers | High Parity Predicts Poor Outcomes in Patients With Luminal B-Like (HER2 Negative) Early Breast Cancer: A Prospective Finnish Single-Center Study
Revisiting the impact of age and molecular subtype on overall survival after radiotherapy in breast cancer patients | Scientific Reports
Impact of molecular subtypes on metastatic breast cancer patients: a SEER population-based study | Scientific Reports
Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients - The Lancet Oncology
Long-term treatment patterns and survival in metastatic breast cancer by intrinsic subtypes – an observational cohort study in Sweden | BMC Cancer | Full Text
